FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma By Ogkologos - May 20, 2026 222 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for safety and efficacy is based on the findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Researchers Have Harnessed a Compound from a Common Plant Called Feverfew... August 2, 2019 On Giving Tuesday, You Helped Us Raise $334,449 For People, Pets,... December 13, 2019 Can Immunotherapy Succeed in Glioblastoma? May 24, 2018 Enhertu May Be Preferred Therapy for Some Metastatic Breast Cancers October 19, 2021 Load more HOT NEWS Pembrolizumab Improves Survival in Patients from Asia with Previously Treated Advanced... Study Tackles Key Questions about Liver Transplants for People with Liver... Rare Disease Day: Raising Awareness for Rare Cancers Cancer Does Not Affect All People Equally: An Expert Q&A on...
